Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Allakos
75 Shoreway Rd., Suite A
San Carlos, CA 94070
Phone: 650-703-8123
www.allakos.com

Allakos Inc. is a privately held, product-focused biotechnology company developing first-in-class antibody-based therapeutics to treat diseases in which dysregulation of the T-helper type 2 (Th2) immune response plays a key role in pathology, including allergic disease, inflammation and diseases characterized by excess production of inflammatory cells. Allakos has generated a preclinical pipeline of novel antibodies targeting cell types implicated in allergic and inflammatory responses, which it intends to advance to clinical proof-of-concept.

Key Contact
Name
Christopher Bebbington
Title
CEO
Funding Events

Date
Amount
Type
Investors
12/17/12 $32,000,000 Series A Alta Partners
Novo Ventures
RiverVest Venture Partners
Roche Venture Fund
09/30/14 $10,000,000 Series A Extension Alta Partners
Novo
Novo Ventures
RiverVest Venture Partners
Roche Venture Fund


Featured Reading